The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 183, Issue 1, Pages 30-36
Publisher
Wiley
Online
2015-06-17
DOI
10.1111/cei.12670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: T Cell Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Juvenile Arthritis Is Contingent Upon Th17 Plasticity
- (2014) Christopher Piper et al. Arthritis & Rheumatology
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
- (2013) Adrian Cortes et al. NATURE GENETICS
- Microbes, the gut and ankylosing spondylitis
- (2013) Mary-Ellen Costello et al. ARTHRITIS RESEARCH & THERAPY
- Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis
- (2012) Sravan K. Payeli et al. ARTHRITIS AND RHEUMATISM
- Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
- (2012) Christina E. Zielinski et al. NATURE
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis
- (2012) D. Jadon et al. RHEUMATOLOGY
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
- (2011) David M Evans et al. NATURE GENETICS
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
- (2011) Heiner Appel et al. ARTHRITIS RESEARCH & THERAPY
- Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese
- (2010) S. I. Davidson et al. ANNALS OF THE RHEUMATIC DISEASES
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats
- (2009) Monica L. DeLay et al. ARTHRITIS AND RHEUMATISM
- Association ofERAP1, but notIL23R, with ankylosing spondylitis in a Han Chinese population
- (2009) Stuart I. Davidson et al. ARTHRITIS AND RHEUMATISM
- T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and Psoriasis
- (2008) Andrew Blauvelt JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now